Clinical Trial Update: A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating pembrolizumab in combination with bavituximab for advanced hepatocellular carcinoma, with results posted and the trial currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bavituximab (bavituximab)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: David Hsieh | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-07-17